Clinical trials
Phase 1 Myasthenia Gravis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arcellx, Inc. | 1 |
| Baltimore VA Medical Center | 1 |
| Cabaletta Bio | 1 |
| Johns Hopkins University | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Kite, A Gilead Company | 1 |
| Muscular Dystrophy Association | 1 |
| Northwestern University | 1 |
| St. Louis University | 1 |
| TG Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 11 |
| Multiple Sclerosis | 3 |
| Autoimmune Diseases | 2 |
| Muscle Weakness | 2 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 |
| Autoimmune Diseases of the Nervous System | 1 |
| Immune System Diseases | 1 |
| Muscular Diseases | 1 |
| Musculoskeletal Diseases | 1 |
| Neuromuscular Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.